Medicinova Inc (MNOV)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Yuichi Iwaki
Employees:
10
4275 EXECUTIVE SQUARE, SUITE 650, LA JOLLA, CA 92037
858-373-1500

MediciNova, Inc. focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders. MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the. treatment of acute exacerbations of asthma, MN-001 (tipelukast) is an orally bioavailable small molecule compound to treat fibrotic diseases.

Data derived from most recent annual or quarterly report
Market Cap 87.302 Million Shares Outstanding49.046 Million Avg 30-day Volume 253.294 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.01
Price to Revenue32.2571 Debt to Equity0.0 EBITDA-10.249 Million
Price to Book Value1.5564 Operating Margin-253.02319999999997 Enterprise Value58.807 Million
Current Ratio25.419 EPS Growth0.323 Quick Ratio25.215
1 Yr BETA 0.9277 52-week High/Low 2.73 / 1.71 Profit Margin-251.0031
Operating Cash Flow Growth13.3448 Free Cash Flow to Firm (FCFF) TTM -8.107 Million Free Cash Flow to Equity (FCFE) TTM-7.18 Million
Altman Z-Score15.2656
View SEC Filings from MNOV instead.

View recent insider trading info

Medicinova Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding MNOV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MNOV

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-08 by LEMEROND NICOLE
  • 3: filed on 2023-08-08 by LEMEROND NICOLE
  • 4: filed on 2023-06-15 by NAGAO HIDEKI
  • 4: filed on 2023-06-15 by BEAVER CAROLYN
  • 4: filed on 2023-01-25 by IWAKI YUICHI
  • 4: filed on 2023-01-25 by OBRIEN GEOFFREY
  • 4: filed on 2023-01-25 by MATSUDA KAZUKO
  • 4: filed on 2022-11-30 by NAGAO HIDEKI
  • 4: filed on 2022-11-23 by NAGAO HIDEKI
  • 4: filed on 2022-11-21 by NAGAO HIDEKI

    • Events (8k)

  • 8-K: filed on 2023-08-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-06-22:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-06-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-04-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-04-05:
    Item 8.01: Other Events
  • 8-K: filed on 2021-08-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LEMEROND NICOLE

    • Director
    		 0 2023-08-04 2

    NAGAO HIDEKI

    • Director
    		 0 2023-06-13 1

    BEAVER CAROLYN

    • Director
    		 0 2023-06-13 1

    IWAKI YUICHI PRESIDENT AND CEO

    • Officer
    • Director
    		 235,125 2023-01-23 1

    MATSUDA KAZUKO CHIEF MEDICAL OFFICER

    • Officer
    • Director
    		 149,625 2023-01-23 1

    OBRIEN GEOFFREY VICE PRESIDENT

    • Officer
    		 76,950 2023-01-23 1

    KRUGER JASON J CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2022-06-16 0

    PAULIN DOUGLAS CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2021-08-01 0

    GAETA FEDERICO C.A. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2021-04-22 0

    3D INVESTMENT PARTNERS PTE. LTD.

    3D OPPORTUNITY MASTER FUND

    • 10% Owner
    		 5,502,047 2021-01-11 0

    STEPANOW EDWARD C JR. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2020-06-19 0

    KOBAYASHI YUTAKA

    • Director
    		 0 2020-06-16 0

    ISHIZAKA YOSHIO

    • Director
    		 0 2019-06-10 0

    OKAJIMA MASATSUNE VP AND HEAD OF JAPANESE OFFICE

    • Officer
    		 1,040,530 2019-02-28 0

    REYES CARLA CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2018-06-01 0

    SELHORN RYAN J CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2016-03-31 0

    VAN DEN BOOM ESTHER CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2014-08-07 0

    IZUMI TATSUO

    • Director
    		 758,730 2013-12-12 0

    MORRIS ARLENE

    • Director
    		 0 2013-05-21 0

    JOHNSON KIRK WILLIAM CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2013-05-13 0

    COFFEE MICHAEL DENIS CHIEF BUSINESS OFFICER

    • Officer
    		 0 2013-05-13 0

    SATOMI HAJIME

    • 10% Owner
    		 1,467,000 2013-05-13 0

    O'TOOLE DAVID D

    • Director
    		 5,000 2012-05-29 0

    SHIGETA HIROAKI

    • Director
    		 45,000 2012-05-10 0

    NAKATA KOUSUKE

    • Director
    		 800,000 2011-11-29 0

    KISSEI PHARMACEUTICAL CO., LTD.

    • 10% Owner
    		 800,000 2011-10-13 0

    GENNARO MICHAEL J CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2011-09-01 0

    PRENDERGAST JOHN K A

    • Director
    		 0 2011-07-18 0

    HIMAWAN JEFF

    • Director
    		 0 2011-06-14 0

    DUNTON ALAN W

    • Director
    		 0 2010-06-11 0

    ASAKO SHINTARO CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2010-01-29 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND II LP

    BVF INVESTMENTS LLC

    BVF INC/IL

    LAMPERT MARK N

    • 10% Owner
    		 0 2009-12-18 0

    KALAFER MICHAEL E CHIEF MEDICAL OFFICER

    • Officer
    		 No longer subject to file 2009-07-28 0

    GAMMANS RICHARD E SR CHIEF DEVELOPMENT OFFICER

    • Officer
    		 0 2009-01-30 0

    VAPNEK DANIEL

    • Director
    		 0 2008-06-09 0

    LOCKE KENNETH W CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2008-01-07 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MEDICINOVA INC MNOV 2023-11-28 22:15:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 21:45:03 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 21:15:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 20:45:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 20:15:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 19:45:03 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 19:15:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 18:45:03 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 18:15:03 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 17:45:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 17:15:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 16:45:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 16:15:04 UTC 3.5005 1.8195 650000
    MEDICINOVA INC MNOV 2023-11-28 15:45:03 UTC 3.3716 1.9484 650000
    MEDICINOVA INC MNOV 2023-11-28 15:15:03 UTC 3.3716 1.9484 650000
    MEDICINOVA INC MNOV 2023-11-28 14:45:04 UTC 3.3716 1.9484 650000
    MEDICINOVA INC MNOV 2023-11-28 14:15:04 UTC 3.3716 1.9484 650000
    MEDICINOVA INC MNOV 2023-11-28 13:45:04 UTC 3.3881 1.9319 650000
    MEDICINOVA INC MNOV 2023-11-28 13:15:03 UTC 3.3881 1.9319 650000
    MEDICINOVA INC MNOV 2023-11-28 12:45:04 UTC 3.3881 1.9319 650000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments